Antengene Announces XPOVIO® (selinexor) Approved for Commercialization in Malaysia ...Middle East

News by : (PR Newswire) -
XPOVIO® is the first and only approved XPO1 inhibitor in Malaysia. XPOVIO® has been approved for multiple indications in eight markets across the APAC region. Antengene has submitted new drug applications (NDAs) for XPOVIO® in other ASEAN markets including Thailand and Indonesia with...

Hence then, the article about antengene announces xpovio selinexor approved for commercialization in malaysia was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Antengene Announces XPOVIO® (selinexor) Approved for Commercialization in Malaysia )

Last updated :

Also on site :

Most Viewed News
جديد الاخبار